BELATACEPT IN RENAL TRANSPLANTATION
Belatacept is a novel immunosuppressive agent that inhibits T-cell activation by blocking CD28 signaling pa- thway. It was developed based on abatacept (CTLA-4Ig), the first recombinant immunoglobulin fusion protein which contains extracellular part of CTLA-4 molecule and Fc domain of IgG. First cli...
Main Authors: | A. I. Sushkov, Y. G. Moysyuk |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov
2013-03-01
|
Series: | Vestnik Transplantologii i Iskusstvennyh Organov |
Subjects: | |
Online Access: | https://journal.transpl.ru/vtio/article/view/146 |
Similar Items
-
A Validated LC-MS/MS Method for Performing Belatacept Drug Monitoring in Renal Transplantation
by: Stéphanie Chhun, et al.
Published: (2023-11-01) -
Combined Immunotherapy With Belatacept and BTLA Overexpression Attenuates Acute Rejection Following Kidney Transplantation
by: Hengcheng Zhang, et al.
Published: (2021-02-01) -
Belatacept and mediastinal histoplasmosis in a kidney transplant patient
by: Hernán Trimarchi, et al.
Published: (2016-04-01) -
Time-Limited Therapy with Belatacept in Kidney Transplant Recipients
by: Thibault Letellier, et al.
Published: (2022-06-01) -
Influence of Belatacept- vs. CNI-Based Immunosuppression on Vascular Stiffness and Body Composition
by: Zbigniew Heleniak, et al.
Published: (2022-02-01)